Talk
Symposium 3: Remote Digital Biomarkers in Alzheimer's Disease Clinical Trials: From Scalable Prescreening to Sensitive AI-Enabled Assessment
Tue, Nov 17, 2026 · 11:05–11:45 AM EST Ballroom - 4th floor, Boston Marriott Copley Place
About this session
Presentations: (1) The voice Clinical Dementia Rating (vCDR) to facilitate clinical assessment for dementia research and trials using a generative AI powered conversational agent; (2) Using digital multi-day learning curves for scalable early detection and tracking of subtle cognitive decline in preclinical AD; (3) Real world feasibility, utility and generalizability of self-administered speech-based testing for scalable pre-screening for Mild Cognitive Impairment: results from the full ADNI4 digital cohort.
Speakers
-
Alzheimer's Therapeutic Research Institute (ATRI), Keck School of Medicine of USC
Chair
-
University of California, San Francisco (UCSF)
Chair
-
University of California, San Francisco (UCSF)
Speaker
-
Center for Alzheimer Research and Treatment, Brigham and Women's Hospital and Massachusetts General Hospital; Harvard Medical School
Speaker
-
Novoic Ltd.
Speaker